HALOPERIDOL TREATMENT OF BEHAVIORAL DISTURBANCES IN ALZHEIMER PATIENTS

被引:0
|
作者
DYSKEN, MW [1 ]
SKARE, SS [1 ]
HOLDEN, L [1 ]
VATASSERY, G [1 ]
机构
[1] VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN,MINNEAPOLIS,MN 55417
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:S81 / S82
页数:2
相关论文
共 50 条
  • [1] EFFECTIVENESS OF ZUCLOPENTHIXOL COMPARED WITH HALOPERIDOL IN THE TREATMENT OF BEHAVIORAL DISTURBANCES IN LEARNING-DISABLED PATIENTS
    MALT, UF
    NYSTAD, R
    BACHE, T
    NOREN, O
    SJAASTAD, M
    SOLBERG, KO
    TONSETH, S
    ZACHARIASSEN, P
    MAEHLUM, E
    BRITISH JOURNAL OF PSYCHIATRY, 1995, 166 : 374 - 377
  • [2] Risperidone, haloperidol, and olanzapine for the treatment of behavioral disturbances in nursing home patients: A retrospective analysis
    Frenchman, IB
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (10): : 742 - 750
  • [3] Pharmacological treatment in behavioral disturbances in Alzheimer's disease
    Suarez Gomez, M.
    Farinha, S.
    Barbosa, P.
    Isaac, J.
    Moura, P.
    Matos-Pires, A.
    Colaco, P.
    Caeiro, L.
    EUROPEAN PSYCHIATRY, 2019, 56 : S177 - S177
  • [4] Advances in the treatment of behavioral disturbances in Alzheimer's disease
    Cummings, JL
    Knopman, D
    NEUROLOGY, 1999, 53 (05) : 899 - 901
  • [5] Topiramate treatment of behavioral disturbances in Alzheimer's disease
    Bruno, G
    Piacentini, E
    Napolitani, I
    Talarico, G
    Ottaviani, D
    Gasparini, M
    Schiaffini, C
    Lenzi, GL
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S93 - S94
  • [6] Metrifonate efficacy in the treatment of psychiatric and behavioral disturbances of Alzheimer's disease patients.
    Cummings, JL
    Cyrus, PA
    Gulanski, B
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) : S65 - S65
  • [7] Pharmacological management of behavioral disturbances in patients with Alzheimer's disease
    Nagata, Tomoyuki
    Shinagawa, Shunichiro
    Nakajima, Shinichiro
    Noda, Yoshihiro
    Mimura, Masaru
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (09) : 1093 - 1102
  • [8] BUSPIRONE VS HALOPERIDOL IN THE TREATMENT OF BEHAVIORAL DISTURBANCES IN A NURSING-HOME POPULATION WITH DEMENTIA
    CANTILLON, M
    LITTLE, J
    BAHRO, M
    BRUNSWICK, R
    MOLINA, D
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1995, 3 (03): : 251 - 251
  • [9] Olanzapine in the treatment of psychosis and behavioral disturbances associated with Alzheimer's disease
    Street, J
    Clark, WS
    Gannon, KS
    Mitan, S
    Kadam, D
    Tamura, R
    Tollefson, GD
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 298 - 298
  • [10] Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's dementia
    De Deyn, PP
    Carrasco, MM
    Deberdt, W
    Jeandel, C
    Hay, DP
    Feldman, PF
    Young, CA
    Lehman, DL
    Breier, A
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A57 - A57